Migraine pain could bring your daily activities to an abrupt halt with its debilitating and throbbing discomfort which is often accompanied by nausea, fatigue, vision changes and more such symptoms. A pathbreaking study has found a new migraine prevention drug - Atogepant - which can provide immediate relief to the people suffering from it, from the very first day of its use
The study published in the online edition of Neurology on the journal of the American Academy of Neurology, has found that people on atogepant were less likely to experience migraines on the first day compared to those taking a placebo. In addition to this, people on this new drug experienced fewer migraines each week during the first four weeks and overall throughout the study than participants who were in the placebo group.
